G1 Therapeutics Earning Date (GTHX)

USA |NASDAQ |USD

GTHX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 2, 2022 Jun 2022 $-0.95 - $-0.94
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 2, 2022 Jun 2022 $9.57M - $6.60M

G1 Therapeutics's next earnings date is Tuesday, Aug 2, 2022 for the fiscal quarter ending Jun 2022.

GTHX Earnings Date & History Chart

GTHX Earnings & Revenue Forecast

GTHX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 8 $-0.95 $-1.13 $-0.89
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 8 $-3.69 $-4.16 $-3.42
Dec 2023 8 $-2.83 $-3.90 $-2.00

GTHX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 1 / 1 $-0.95 $-0.99 $-0.99
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 1 / 1 $-3.70 $-3.88 $-3.87
Dec 2023 0 / 1 $-2.81 $-3.01 $-3.15

GTHX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 8 $9.57M $6.80M $11.10M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 8 $43.88M $29.50M $53.91M
Dec 2023 8 $84.81M $57.50M $115.72M

GTHX Earnings Date & Revenue History

GTHX Earnings History

|
Show More
Show More

GTHX Revenue History

|
Show More
Show More

G1 Therapeutics Next Earnings Date & Report

GTHX Next Earnings Date & Report Preview: Jun 2022 (FQ)

GTHX's next earnings date is Tuesday, Aug 2, 2022 for the fiscal quarter ending Jun 30, 2022.

According to analysts, the average EPS estimation for G1 Therapeutics's next quarterly earnings is $-0.95, with a low EPS estimation of $-1.13, and a high estimation of $-0.89.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 1 downward. The EPS 1 month trend is $-0.95, the last 2 month trend is $-0.99, and the 3 month trend is $-0.99.

Based on analysts, the average revenue estimation is $9.57M, with a low revenue estimation of $6.80M, and a high estimation of $11.10M.

G1 Therapeutics Previous Earnings Dates & Reports

GTHX Previous Earnings Date & Report Recap: Mar 2022 (FQ)

G1 Therapeutics's previous earnings date was May 3, 2022 for its fiscal quarter ended Mar 31, 2022.

GTHX Previous Earnings Date & Report Recap: Dec 2021 (FY)

G1 Therapeutics's previous annual earnings date was Feb 23, 2022 for its fiscal year ended Dec 31, 2021.

GTHX's earnings per share (EPS) was $-3.53, beating the consensus analysts forecast of $-3.63 by -2.75% , and lower than the previous year's EPS (Dec 2020) by 34.22%.

Revenues were $31.48M, better than the forecast of $31.40M by 0.24%, and down by -30.49% from previous year's revenue.

The company reported a net income of $-148.35M.

G1 Therapeutics reported a free cash flow of $-132.11M for its fiscal year, compared to $-83.74M a year ago.

The company ended the fiscal year with $83.06M in total debt, an increase of 199.21% compared to the previous year.